Status:
UNKNOWN
Computer-based Training of Face Recollection to Improve Face Recognition in Developmental Prosopagnosia
Lead Sponsor:
Boston VA Research Institute, Inc.
Conditions:
Developmental Prosopagnosia
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
This study will examine the effectiveness of a cognitive training intervention targeting face recollection, repetition lag training, at improving face recognition in Developmental Prosopagnosia.
Eligibility Criteria
Inclusion
- Developmental prosopagnosic participants will be included if they are...
- aged 18-90,
- have lifelong histories of face recognition difficulties that impact their everyday life (i.e., not associated with some event such as a stroke, seizure, etc)
- score significantly below the mean on the famous faces test and Cambridge Face Memory Test
Exclusion
- Participants will be excluded from the study if they...
- have a history of a significant neurological disorder including hydrocephalus, stroke, moderate to severe traumatic brain injury (TBI), severe neuromuscular diseases, or severe hypoxia due to cardiac arrest.
- have impairments that interfere with cognitive performance, such as uncorrected hearing or vision, lack of English proficiency, musculoskeletal or other issues
- have psychiatric disorders, such as schizophrenia, major depressive disorder, bipolar disorder, chronic intractable obsessive-compulsive disorder, or agoraphobia.
- We will exclude individuals who are currently dependent on alcohol or other substances, as this may negatively impact cognitive performance.
- We will exclude participants who currently are, or within the last 6 months, participating in a behavioral or pharmacological intervention.
- Patients with a history of mild TBI or simple concussion will not be excluded as long as it was \> 6 months ago and as long as they have not had repeated concussions (\>5)
- We will include individuals with a diagnosis of ADHD as long as their medication has been consistent for the past 6 months.
Key Trial Info
Start Date :
March 12 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04799340
Start Date
March 12 2021
End Date
July 1 2025
Last Update
November 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Boston Healthcare System, 150 S. Huntington Ave.
Boston, Massachusetts, United States, 02130